Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Palatin TechnologiesFRA:PTN 19 Market Cap is €12.05 Mil as of Jul. 26, 2026. GuruFocus rates FRA:PTN with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 1,423 Biotechnology companies, Palatin Technologies ranks worse than 80.82% on this metric.
Palatin Technologies's quarterly market cap
increased
from Sep. 2025 (€3.21 Mil) to Dec. 2025 (€5.80 Mil) and
increased
from Dec. 2025 (€5.80 Mil) to Mar. 2026 (€5.86 Mil).
Palatin Technologies's annual market cap
increased
from Jun. 2023 (€22.48 Mil) to Jun. 2024 (€31.59 Mil) but then
declined
from Jun. 2024 (€31.59 Mil) to Jun. 2025 (€3.07 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Palatin Technologies's Enterprise Value for Today is €3.37 Mil.
Palatin Technologies (FRA:PTN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Palatin Technologies Market Cap Related Terms
Palatin Technologies Market Cap Historical Data
* Premium members only.
The historical data trend for Palatin Technologies's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PTN vs LPCN, NCEL, CLRB: Market Cap Comparison
For the Biotechnology subindustry, Palatin Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Palatin Technologies Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Palatin Technologies's Market Cap distribution charts can be found below:
* The bar in red indicates where Palatin Technologies's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Palatin Technologies's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Palatin Technologies (FRA:PTN) has a Market Cap of €12.05 Mil as of Jul. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Palatin Technologies and its competitors. According to the industry distribution chart, Palatin Technologies ranks #1150 out of 1423 companies in the Biotechnology industry, placing it in the top 80.8%.
Is Palatin Technologies' Market Cap too high?
Palatin Technologies' current Market Cap is €12.05 Mil. Based on the distribution chart, Palatin Technologies ranks #1150 out of 1423 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Palatin Technologies has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Palatin Technologies' Market Cap compare to LPCN and NCEL?
According to the Biotechnology industry distribution chart, Palatin Technologies ranks #1150 out of 1423 companies for Market Cap. This places Palatin Technologies in the lower half of its industry. The industry median Market Cap is 112.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 112.84, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Palatin Technologies and its competitors. For the Biotechnology industry, the median Market Cap is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Palatin Technologies's current Market Cap is €12.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Palatin Technologies stock overvalued right now?
Palatin Technologies (FRA:PTN) has a current Market Cap of €12.05 Mil. The current Market Cap is €12.05 Mil. Palatin Technologies' overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Palatin Technologies (FRA:PTN), the current Market Cap is €12.05 Mil as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
19GF Score
Get the complete analysis for FRA:PTN
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PTN has been successfully added to your 
